Molecular hydrogen affects body composition, metabolic profiles, and mitochondrial function in middle-aged overweight women.
D Korovljev, T Trivic, P Drid, S M Ostojic · Irish journal of medical science · 2018
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In 10 middle-aged participants, it appears that orally administered H₂ as a blend of hydrogen-generating minerals might be a beneficial agent in the management of body composition and insulin resistance in obesity. These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence glucose regulation and metabolic health.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in 10 middle-aged participants. It appears that orally administered H₂ as a blend of hydrogen-generating minerals might be a beneficial agent in the management of body composition and insulin resistance in obesity.
What the Researchers Studied
The researchers studied 10 middle-aged participants. The study used a placebo-controlled human clinical trial. The comparison condition was placebo.
What Effects Did Molecular Hydrogen Have?
Reported treatment duration: 4 weeks. It appears that orally administered H₂ as a blend of hydrogen-generating minerals might be a beneficial agent in the management of body composition and insulin resistance in obesity.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence glucose regulation and metabolic health and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a placebo-controlled human clinical trial. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was 10 middle-aged participants. The study used a placebo-controlled human clinical trial. The reported treatment duration was 4 weeks.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.